Department of Developmental Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 187-8553, Japan.
Behav Brain Res. 2013 Jan 15;237:325-32. doi: 10.1016/j.bbr.2012.09.051. Epub 2012 Oct 5.
This study investigated the roles of cholecystokinin (CCK)(A) and CCK(B) receptors on CCK-4-induced anxiety-like behaviors in mice through behavioral and neural evaluations. Anxiety-like behaviors in mice were induced by an intracerebroventricular (i.c.v.) administration of CCK-4, which can bind to both CCK(A) and CCK(B) receptors. The effects of CCK(A) and CCK(B) receptor antagonists (devazepide and CI-988, respectively) were examined using mouse anxiety tests (elevated-plus maze and light-dark box) and also by examining neuronal activities through EEG monitoring and c-Fos immunohistochemistry in the cortex and amygdala. CCK-4 (3 μg/kg of body weight i.c.v.) significantly induced mouse anxiety-like behaviors in the anxiety tests and also affected their EEG patterns with respect to pre-drug tracing, resulting in increase in spectral power in relative power distribution in the delta and theta bands (0.5-5 Hz frequency bands) and also in increase in c-Fos immunopositive neuron counts. These CCK-4 effects were completely suppressed by 1.0mg/kg CCK(B) receptor antagonist, CI-988, while the same amount of CCK(A) receptor antagonist, devazepide was partly able to suppress the same effects. These findings indicated that not only CCK(B) receptors but also CCK(A) receptors in the brain play important roles in regulating anxiety-like behaviors in mice. The present study also proposed a possibility that cortical EEG is useful for assessing anxiety.
本研究通过行为和神经评估,探讨了胆囊收缩素(CCK)(A)和 CCK(B)受体在 CCK-4 诱导小鼠焦虑样行为中的作用。通过侧脑室(i.c.v.)给予 CCK-4 诱导小鼠焦虑样行为,CCK-4 可与 CCK(A)和 CCK(B)受体结合。使用小鼠焦虑测试(高架十字迷宫和明暗箱)和通过 EEG 监测和皮质和杏仁核中的 c-Fos 免疫组化检查神经元活动,检查了 CCK(A)和 CCK(B)受体拮抗剂(分别为 devazepide 和 CI-988)的作用。CCK-4(3μg/kg 体重 i.c.v.)在焦虑测试中显著诱导了小鼠的焦虑样行为,并且还影响了它们的 EEG 模式,与预给药追踪相比,导致在 delta 和 theta 波段(0.5-5 Hz 频段)的相对功率分布中谱功率增加,并且 c-Fos 免疫阳性神经元计数增加。这些 CCK-4 作用完全被 1.0mg/kg CCK(B)受体拮抗剂 CI-988 抑制,而相同量的 CCK(A)受体拮抗剂 devazepide 部分能够抑制相同的作用。这些发现表明,不仅大脑中的 CCK(B)受体,而且 CCK(A)受体在调节小鼠焦虑样行为中也发挥重要作用。本研究还提出了一种可能性,即皮层 EEG 可用于评估焦虑。